1. 首页
  2. 细胞
  3. 正文

Tasquinimod_254964-60-8_Absin

产品信息
抗原名称
HDAC4
商品描述

Tasquinimod is an orally active antiangiogenic agent by allosterically inhibiting HDAC4 signalling. Phase 3.

分子量
406.36
纯度

>98%

可溶性
DMSO :81 mg/mL (199.33 mM)
Ethanol :11 mg/mL warmed (27.06 mM)
外观
White to light yellow Powder
In vitro(体外研究)
Tasquinimod inhibits tumor angiogenesis by allosteric inhibition of HDAC4/N-CoR/HDAC3 dependent deacetylation of HIF-1α. Tasquinimod also targets infiltrating myeloid cells, and modulates local tumour immunity by blocking the interaction between S100A9 and its ligands receptor of advanced glycation end products and Toll-like receptor 4.
In vivo(体内研究)
Tasquinimod (30 mg/kg/d p.o.) shows anti-angiogenic activity and thus causes tumor growth inhibition in mice bearing human and rodent prostate cancer models.
背景
别名
他喹莫德
分子式
C20H17F3N2O4
CAS号
254964-60-8
制备和贮存
保存方式
Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution.

参考图片

文档下载: W 导出为Tasquinimod_254964-60-8_Absin.doc文档

本文来自投稿,不代表本人立场,如若转载,请注明出处:http://www.iamyjet.com/article/21474.html

(function(){ var src = (document.location.protocol == "http:") ? "http://js.passport.qihucdn.com/11.0.1.js?1d7dde81dc0903e04d3ac0b9599444f6":"https://jspassport.ssl.qhimg.com/11.0.1.js?1d7dde81dc0903e04d3ac0b9599444f6"; document.write('<\/mip-script>'); })(); (function(){ var bp = document.createElement('script'); var curProtocol = window.location.protocol.split(':')[0]; if (curProtocol === 'https') { bp.src = 'https://zz.bdstatic.com/linksubmit/push.js'; } else { bp.src = 'http://push.zhanzhang.baidu.com/push.js'; } var s = document.getElementsByTagName("script")[0]; s.parentNode.insertBefore(bp, s); })();